NASDAQ:VLRX - Valeritas Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.49 -0.05 (-3.25 %)
(As of 07/23/2018 06:23 AM ET)
Previous Close$1.54
Today's Range$1.48 - $1.59
52-Week Range$1.19 - $6.79
Volume250,286 shs
Average Volume2.05 million shs
Market Capitalization$35.23 million
P/E Ratio-0.18
Dividend YieldN/A
Beta4.3
Valeritas logoValeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery. In addition, its products include V-Go Prefill, which is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go Link that is in the early stages of development for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors in the United States. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.

Receive VLRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VLRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VLRX
CUSIPN/A
Phone908-927-9920

Debt

Debt-to-Equity Ratio-2.57
Current Ratio2.56
Quick Ratio1.80

Price-To-Earnings

Trailing P/E Ratio-0.18
Forward P/E Ratio-0.51
P/E GrowthN/A

Sales & Book Value

Annual Sales$20.25 million
Price / Sales1.74
Cash FlowN/A
Price / CashN/A
Book Value($0.59) per share
Price / Book-2.53

Profitability

EPS (Most Recent Fiscal Year)($8.29)
Net Income$-49,300,000.00
Net Margins-225.97%
Return on Equity-1,768.69%
Return on Assets-90.30%

Miscellaneous

Employees103
Outstanding Shares23,640,000
Market Cap$35.23

Valeritas (NASDAQ:VLRX) Frequently Asked Questions

What is Valeritas' stock symbol?

Valeritas trades on the NASDAQ under the ticker symbol "VLRX."

How were Valeritas' earnings last quarter?

Valeritas Holdings Inc (NASDAQ:VLRX) announced its quarterly earnings data on Wednesday, May, 9th. The company reported ($1.72) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.13) by $0.41. The company earned $6.08 million during the quarter, compared to analysts' expectations of $6 million. Valeritas had a negative net margin of 225.97% and a negative return on equity of 1,768.69%. View Valeritas' Earnings History.

What price target have analysts set for VLRX?

3 analysts have issued 1-year target prices for Valeritas' stock. Their forecasts range from $3.50 to $3.50. On average, they anticipate Valeritas' stock price to reach $3.50 in the next year. This suggests a possible upside of 134.9% from the stock's current price. View Analyst Ratings for Valeritas.

What is the consensus analysts' recommendation for Valeritas?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Valeritas in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Are investors shorting Valeritas?

Valeritas saw a increase in short interest in the month of June. As of June 29th, there was short interest totalling 1,349,856 shares, an increase of 113.6% from the June 15th total of 631,983 shares. Based on an average daily trading volume, of 3,498,152 shares, the days-to-cover ratio is presently 0.4 days. Currently, 6.9% of the company's shares are short sold. View Valeritas' Current Options Chain.

Who are some of Valeritas' key competitors?

Who are Valeritas' key executives?

Valeritas' management team includes the folowing people:
  • Mr. John E. Timberlake, CEO, Pres & Director (Age 53)
  • Mr. Erick J. Lucera CPA, CFA, CFO & Sec. (Age 50)
  • Mr. Geoffrey H. Jenkins, Exec. VP of Manufacturing, Operations and R&D (Age 66)
  • Dr. Matthew H. Nguyen, Chief Commercial Officer (Age 48)
  • Mr. Mark Conley, VP, Principal Accounting Officer, Corp. Controller & Treasurer (Age 56)

When did Valeritas IPO?

(VLRX) raised $60 million in an initial public offering (IPO) on Thursday, March 23rd 2017. The company issued 6,000,000 shares at a price of $9.00-$11.00 per share. Cowen and Company and Wedbush PacGrow acted as the underwriters for the IPO and Roth Capital Partners and B. Riley & Co. were co-managers.

Has Valeritas been receiving favorable news coverage?

News coverage about VLRX stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Valeritas earned a media sentiment score of 0.24 on Accern's scale. They also gave media stories about the company an impact score of 46.73 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Who are Valeritas' major shareholders?

Valeritas' stock is owned by many different of institutional and retail investors. Top institutional investors include Essex Investment Management Co. LLC (1.35%). Company insiders that own Valeritas stock include Brian K Roberts, Capital Royalty LP, Erick Lucera, Geoffrey Jenkins, John Edward Timberlake, Joseph M Mandato, Matt Nguyen and Matt Nguygn. View Institutional Ownership Trends for Valeritas.

Which major investors are buying Valeritas stock?

VLRX stock was bought by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC. Company insiders that have bought Valeritas stock in the last two years include Brian K Roberts, Capital Royalty LP, Erick Lucera, Geoffrey Jenkins, John Edward Timberlake, Joseph M Mandato, Matt Nguyen and Matt Nguygn. View Insider Buying and Selling for Valeritas.

How do I buy shares of Valeritas?

Shares of VLRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Valeritas' stock price today?

One share of VLRX stock can currently be purchased for approximately $1.49.

How big of a company is Valeritas?

Valeritas has a market capitalization of $35.23 million and generates $20.25 million in revenue each year. The company earns $-49,300,000.00 in net income (profit) each year or ($8.29) on an earnings per share basis. Valeritas employs 103 workers across the globe.

How can I contact Valeritas?

Valeritas' mailing address is 750 ROUTE 202 SOUTH SUITE 600, BRIDGEWATER NJ, 08807. The company can be reached via phone at 908-927-9920 or via email at [email protected]


MarketBeat Community Rating for Valeritas (NASDAQ VLRX)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  197
MarketBeat's community ratings are surveys of what our community members think about Valeritas and other stocks. Vote "Outperform" if you believe VLRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VLRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/23/2018 by MarketBeat.com Staff

Featured Article: Relative Strength Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.